Suggestions
Ingmar Gorman
Co-Founder and CEO at Fluence, MAPS Clinical Investigator, and Psychologist
Ingmar Gorman is an experienced Principal Investigator with a strong background in psychedelic psychotherapy research.
He has honed his skills in public speaking, psychotherapy, clinical trials, and teaching.
Ingmar received comprehensive training including a NIH Postdoctoral Fellowship at New York University, a psychology clinical internship at Bellevue Hospital, and externships at Mount Sinai Hospital and Columbia University.
His educational journey includes a Doctoral Degree in Psychology from The New School, a NIH Postdoctoral Fellowship in Drug Abuse Research at New York University, and a Bachelor's degree in Psychology from New College of Florida.
Ingmar Gorman's professional experience spans across various reputable organizations. He currently serves as the Chief Executive Officer & Co-Founder at Fluence.
His previous roles include Clinical Investigator at Multidisciplinary Association for Psychedelic Studies (MAPS), Advisory Board Member at Journey Clinical Inc., Director at Psychedelic Education and Continuing Care Program, and Psychologist at Center for Optimal Living.
Ingmar has also held positions as Site Co-Principle Investigator, Co-Investigator, and Psychology Extern at different branches of Multidisciplinary Association for Psychedelic Studies (MAPS).
His diverse experience includes being a Clinical Psychology Intern at Bellevue Hospital Center, a Clinical Psychology Extern at Columbia University Center for Psychoanalytic Training and Research, and a Psychology Extern at South Beach Psychiatric Center.
Additionally, Ingmar Gorman has been involved in research and assistant roles at institutions such as Memorial Sloan-Kettering Cancer Center, Beth Israel Medical Center, and Psychiatric Hospital Bohnice in Prague.
